| 000 | 01804 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518020958.0 | ||
| 264 | 0 | _c20190729 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1754-8411 | ||
| 024 | 7 |
_a10.1242/dmm.036004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelgadillo-Silva, Luis Fernando | |
| 245 | 0 | 0 |
_aModelling pancreatic β-cell inflammation in zebrafish identifies the natural product wedelolactone for human islet protection. _h[electronic resource] |
| 260 |
_bDisease models & mechanisms _c01 2019 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Genetically Modified |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiological Products _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCoumarins _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGlucose _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xgenetics |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 |
_aInsulin-Secreting Cells _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-1beta _xmetabolism |
| 650 | 0 | 4 |
_aLarva _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Genetic |
| 650 | 0 | 4 | _aTime-Lapse Imaging |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aZebrafish |
| 700 | 1 | _aTsakmaki, Anastasia | |
| 700 | 1 | _aAkhtar, Nadeem | |
| 700 | 1 | _aFranklin, Zara J | |
| 700 | 1 | _aKonantz, Judith | |
| 700 | 1 | _aBewick, Gavin A | |
| 700 | 1 | _aNinov, Nikolay | |
| 773 | 0 |
_tDisease models & mechanisms _gvol. 12 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1242/dmm.036004 _zAvailable from publisher's website |
| 999 |
_c29289576 _d29289576 |
||